Jordan D. Awerbach, M.D., M.P.H
The impact of Fontan-associated liver disease (FALD) on post-transplant mortality and indications for combined heart-liver transplant (CHLT) in adult Fontan patients remains unknown.
The purpose of this study was to assess the impact of FALD on post-transplant outcomes and compare HT vs. CHLT in adult Fontan patients.
Additional Authors: please see study.
The views, opinions, and conclusions expressed herein are solely those of the authors. Reference to any specific commercial products, process, or service by trade name, trademark, manufacturer, or otherwise, does not necessarily constitute or imply endorsement, recommendation, or favoring by Phoenix Children’s.